Literature DB >> 22251884

Novel peptide ligand with high binding capacity for antibody purification.

Line Naomi Lund1, Per-Erik Gustavsson, Roice Michael, Johan Lindgren, Leif Nørskov-Lauritsen, Martin Lund, Gunnar Houen, Arne Staby, Phaedria M St Hilaire.   

Abstract

Small synthetic ligands for protein purification have become increasingly interesting with the growing need for cheap chromatographic materials for protein purification and especially for the purification of monoclonal antibodies (mAbs). Today, Protein A-based chromatographic resins are the most commonly used capture step in mAb down stream processing; however, the use of Protein A chromatography is less attractive due to toxic ligand leakage as well as high cost. Whether used as an alternative to the Protein A chromatographic media or as a subsequent polishing step, small synthetic peptide ligands have an advantage over biological ligands; they are cheaper to produce, ligand leakage by enzymatic degradation is either eliminated or significantly reduced, and they can in general better withstand cleaning in place (CIP) conditions such as 0.1M NaOH. Here, we present a novel synthetic peptide ligand for purification of human IgG. Immobilized on WorkBeads, an agarose-based base matrix from Bio-Works, the ligand has a dynamic binding capacity of up to 48 mg/mL and purifies IgG from harvest cell culture fluid with purities and recovery of >93%. The binding affinity is ∼10⁵ M⁻¹ and the interaction is favorable and entropy-driven with an enthalpy penalty. Our results show that the binding of the Fc fragment of IgG is mediated by hydrophobic interactions and that elution at low pH is most likely due to electrostatic repulsion. Furthermore, we have separated aggregated IgG from non-aggregated IgG, indicating that the ligand could be used both as a primary purification step of IgG as well as a subsequent polishing step.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22251884     DOI: 10.1016/j.chroma.2011.12.074

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  7 in total

1.  Antibody purification via affinity membrane chromatography method utilizing nucleotide binding site targeting with a small molecule.

Authors:  Nur Mustafaoglu; Tanyel Kiziltepe; Basar Bilgicer
Journal:  Analyst       Date:  2016-11-28       Impact factor: 4.616

2.  Affinity Sedimentation and Magnetic Separation With Plant-Made Immunosorbent Nanoparticles for Therapeutic Protein Purification.

Authors:  Matthew J McNulty; Anton Schwartz; Jesse Delzio; Kalimuthu Karuppanan; Aaron Jacobson; Olivia Hart; Abhaya Dandekar; Anatoli Giritch; Somen Nandi; Yuri Gleba; Karen A McDonald
Journal:  Front Bioeng Biotechnol       Date:  2022-04-27

3.  Trastuzumab-Peptide interactions: mechanism and application in structure-based ligand design.

Authors:  Tian-Yang Sun; Qi Wang; Jin Zhang; Tao Wu; Fan Zhang
Journal:  Int J Mol Sci       Date:  2013-08-15       Impact factor: 5.923

Review 4.  Fc-Binding Ligands of Immunoglobulin G: An Overview of High Affinity Proteins and Peptides.

Authors:  Weonu Choe; Trishaladevi A Durgannavar; Sang J Chung
Journal:  Materials (Basel)       Date:  2016-12-08       Impact factor: 3.623

5.  A novel fluorescence immunochromatographic assay strip for the diagnosis of schistosomiasis japonica.

Authors:  Yuanxi Shen; Rongyi Ji; Rui Chai; Nana Yuan; Jiyue Zhang; Yi Jing; Man Yang; Lanqi Zhang; Yang Hong; Jiaojiao Lin; Chuangang Zhu
Journal:  Parasit Vectors       Date:  2021-01-06       Impact factor: 3.876

6.  Design and preliminary application of affinity peptide based on the structure of the porcine circovirus type II Capsid (PCV2 Cap).

Authors:  Junfang Hao; Fangyu Wang; Guangxu Xing; Yunchao Liu; Ruiguang Deng; Hao Zhang; Anchun Cheng; Gaiping Zhang
Journal:  PeerJ       Date:  2019-12-05       Impact factor: 2.984

Review 7.  Peptide Affinity Chromatography Applied to Therapeutic Antibodies Purification.

Authors:  Gabriela R Barredo-Vacchelli; Silvana L Giudicessi; María C Martínez-Ceron; Osvaldo Cascone; Silvia A Camperi
Journal:  Int J Pept Res Ther       Date:  2021-10-19       Impact factor: 1.931

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.